NVAX Novavax, Inc.
$10.78
Novavax, Inc. (NVAX) Earnings News
Earnings press releases, previews and reviews for Novavax, Inc. (NVAX), newest first. Our most recent is review: Novavax Beats on a Narrower Loss and Lifts Its Outlook on Sanofi's $125 Million Milestone, but Its Profitability Target Slides to 2029.
Thursday
November 5, 2026
11:57 AM ET
Novavax Beats on a Narrower Loss and Lifts Its Outlook on Sanofi's $125 Million Milestone, but Its Profitability Target Slides to 2029
Earnings Whispers · Review
Thursday
November 5, 2026
8:00 AM ET
Novavax Reports Third Quarter 2026 Financial Results and Operational Highlights
Thursday
October 29, 2026
11:57 AM ET
Novavax Heads Into Q3 Report Needing Sanofi Launch Evidence to Justify Its Rally
Earnings Whispers · Preview
Thursday
October 29, 2026
8:00 AM ET
Novavax to Report Third Quarter 2026 Financial Results on November 5, 2026
Thursday
August 6, 2026
8:00 AM ET
Novavax Reports Second Quarter 2026 Financial Results and Operational Highlights
Thursday
July 30, 2026
7:00 AM ET
Novavax to Report Second Quarter 2026 Financial Results on August 6, 2026